Plano, Texas (PRWEB) December 18, 2012
As a reproductive endocrinologist, Dr. James Douglas specializes in helping infertile women have children. In some cases, patients do not respond well to fertility treatments, and may mistakenly believe that donor eggs are the only option. To help couples explore alternative therapies before moving to donor eggs, Dr. Douglas has begun utilizing human growth hormone (HGH) to give these patients additional choices.
“I understand the strong desire for a biological child,” explained Dr. Douglas. “We have seen success with HGH therapy in certain cases, and are now recommending it as a course of treatment for some of our poor responding patients.”
Typically, "poor responders" are patients that require increased dosing of gonadotropin therapy, have poor ovarian reserve testing and are over 35. Fertility specialists routinely see this type patients in their offices.
“Often, these women have tried in-vitro fertilization (IVF), and the cycles then failed to result in pregnancy, or were cancelled due to lack of response to medication,” Dr. Douglas said.
The benefits of HGH treatment coupled with ovarian stimulation were first reported 20 years ago. However, this treatment never gained widespread use despite studies touting the benefits.
“More studies are becoming available to support HGH therapy, and the fertility community is responding accordingly,” said Dr. Douglas.
With HGH therapy, patients take subcutaneous injections for six days during the stimulation stage
Copyright©2012 Vocus, Inc.
All rights reserved